Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey

Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey

Abstract Background Patients with hereditary angioedema (HAE) due to C1-inhibitor deficiency (C1-INH-HAE) experience recurrent attacks of cutaneous or submucosal edema that may be frequent and severe; prophylactic treatments can be prescribed to prevent attacks. However, despite the use of long-term...

Full description

Bibliographic Details
Main Authors: Werner Aberer, Marcus Maurer, Laurence Bouillet, Andrea Zanichelli, Teresa Caballero, Hilary J. Longhurst, Amandine Perrin, Irmgard Andresen, for the IOS Study Group
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Hereditary angioedema
Icatibant
Breakthrough attacks
Prophylaxis
Bradykinin
Online Access:http://link.springer.com/article/10.1186/s13223-017-0203-z

Internet

http://link.springer.com/article/10.1186/s13223-017-0203-z

Similar Items